Guak et al. reported that glycolysis-cholesterol metabolic axis activation significantly supported the CCR7 aggregation and DCs migration to tumor foci, thereby promoting thrive anti-tumor immune cells, even in the absence of mitochondrial metabolism [62, 63]. This evidence concerns the gene CCR7 and neoplasm.